Proanthocyanidin from grape seeds potentiates anti-tumor activity of doxorubicin via immunomodulatory mechanism
Authors:
- Xiao-Yu ZhangXZXiao-Yu Zhang
- Wen-Guang LiWLWen-Guang Li
- Yong-Jie WuYWYong-Jie Wu
- Tian-Zhen ZhengTZTian-Zhen Zheng
- Wei LiWLWei Li
- Song-Yi QuSQSong-Yi Qu
- Nai-Fa LiuNLNai-Fa Liu
- 1 July 2005
- journal article
- Published by Elsevier in International Immunopharmacology
- Vol. 5 (7-8) , 1247-1257
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Synergistic Anti-Cancer Effects of Grape Seed Extract and Conventional Cytotoxic Agent Doxorubicin Against Human Breast Carcinoma CellsBreast Cancer Research and Treatment, 2004
- Grape seed extract inhibits advanced human prostate tumor growth and angiogenesis and upregulates insulin‐like growth factor binding protein‐3International Journal of Cancer, 2003
- Importance of CD4+ Helper T-cells in Antitumor ImmunityInternational Journal of Hematology, 2003
- Molecular mechanisms of cardioprotection by a novel grape seed proanthocyanidin extractMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 2003
- Cellular Protection with Proanthocyanidins Derived from Grape SeedsAnnals of the New York Academy of Sciences, 2002
- Protective Effects of Grape Seed Proanthocyanidins and Selected Antioxidants against TPA-Induced Hepatic and Brain Lipid Peroxidation and DNA Fragmentation, and Peritoneal Macrophage Activation in MiceGeneral Pharmacology: The Vascular System, 1998
- Anthracyclines in haematology: preclinical studies, toxicity and delivery systemsBlood Reviews, 1997
- Cardiac toxicity 4 to 20 years after completing anthracycline therapy1991
- Evidence for the role of natural immunity in the control of metastatic spread of head and neck cancerCancer Immunology, Immunotherapy, 1987
- Anthracycline analogs The past, present, and futureCancer Chemotherapy and Pharmacology, 1986